ClearPoint Neuro (CLPT) Non-Current Deffered Revenue (2018 - 2026)
ClearPoint Neuro recorded quarterly Non-Current Deffered Revenue of $608000.0 in Q1 2026, up 4.65% quarter-over-quarter from $581000.0 in Q4 2025, and up 70.31% year-over-year from $357000.0 in Q1 2025.
ClearPoint Neuro's Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $608000.0 for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue rose 70.31% year-over-year to $608000.0; the TTM figure through Mar 2026 stood at $608000.0 (up 70.31% YoY), while the FY2025 annual figure was $581000.0, up 33.26% from the prior year.
- Non-Current Deffered Revenue came in at $608000.0 for Q1 2026 at ClearPoint Neuro, up from $581000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $769000.0 in Q3 2025 to a low of $253000.0 in Q2 2023.
- A 5-year average of $466235.3 and a median of $446000.0 in 2024 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue slumped 36.91% in 2023 and soared 76.28% in 2024, its largest moves.
- ClearPoint Neuro's Non-Current Deffered Revenue stood at $390000.0 in 2022, then soared by 38.72% to $541000.0 in 2023, then decreased by 19.41% to $436000.0 in 2024, then jumped by 33.26% to $581000.0 in 2025, then grew by 4.65% to $608000.0 in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $608000.0, $581000.0, and $769000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 608,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 608,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Sep 30, 2025 | 769,000.00 |
| Jun 30, 2025 | 603,000.00 |
| Mar 31, 2025 | 357,000.00 |
| Dec 31, 2024 | 436,000.00 |
| Sep 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 458,000.00 |
| Dec 31, 2023 | 541,000.00 |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 253,000.00 |
| Mar 31, 2023 | 320,000.00 |
| Dec 31, 2022 | 390,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 401,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Dec 31, 2021 | 264,000.00 |
| Sep 30, 2021 | 310,000.00 |
| Jun 30, 2021 | 268,000.00 |
| Mar 31, 2021 | 318,000.00 |
| Dec 31, 2020 | 215,000.00 |
| Sep 30, 2020 | 108,816.00 |
| Jun 30, 2020 | 228,286.00 |
| Mar 31, 2020 | 148,150.00 |
| Dec 31, 2019 | 198,000.00 |
| Dec 31, 2018 | 140,195.00 |